Bruce Japsen, Senior Contributor

Author's posts

As Johnson & Johnson’s One-Shot Covid-19 Vaccine Joins The Fight, Hesitancy Could Subside

The addition of Johnson & Johnson’s single-dose vaccine in the U. S. could spur more Americans to get immunized against Covid-19 and further reduce vaccine hesitancy, polls indicate.

Cigna’s Evernorth To Buy Telehealth Provider MDLive

Cigna’s Evernorth healthcare services business will buy MDLive, a fast-growing provider of telehealth services that have taken off during the Covid-19 pandemic.

CVS To Expand Covid-19 Vaccinations To Pharmacies In 17 States

CVS Health said it will begin receiving at least 570,000 Covid-19 vaccine doses weekly as part of the broader effort to increase vaccination at U. S. pharmacies in 17 states.

CVS Health’s Housing Investments Reach $114 Million As Insurers Address Social Determinants

CVS Health will increase investments in affordable housing to address social determinants of health.

Walgreens To Expand Covid-19 Vaccination To Pharmacies In 23 States

Walgreens said it will begin receiving more than 480,000 Covid-19 vaccine doses a week as part of the broader Biden administration effort to increase vaccination at U.S. pharmacies.

CVS To Finish Nursing Home, Assisted Living Covid-19 Vaccinations By Mid-March

CVS Health says it will complete vaccinating residents of more than 40,000 long-term care facilities across the U. S. by mid-March.

CVS Health Will Return Aetna To Obamacare Market

CVS Health said it will re-enter the business of selling individual coverage under the Affordable Care Act next year.

Zocdoc, Growing As Vaccine Appointment Scheduler, Raises $150 Million

Zocdoc has raised $150 million – the biggest single funding round yet for the company that has found a niche helping Americans schedule Covid-19 vaccination appointments.

Molina Latest Health Insurer Hit By Rising Covid-19 Costs

Molina Healthcare’s profits dipped in the fourth quarter and for the full year of 2020 as the Covid-19 pandemic triggered rising expenses and an uptick in medical claims for the health insurer.

Johnson & Johnson CEO: Our Covid-19 Vaccine Will Keep You From Getting ‘Very, Very Sick’

Johnson & Johnson’s one-shot vaccine against Covid-19 will keep patients from getting sick and hospitalized as a critical option for patients around the world, the company’s CEO said Tuesday.